Expanded Access for ATB200/AT2221 for the Treatment of Pompe Disease

Summary

This is an expanded access program (EAP) for eligible participants designed to provide access to ATB200/AT2221.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications